15-ICML - International Conference on Malignant Lymphoma
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
15th International Conference on Malignant Lymphoma (ICML)
organized by the Foundation for the Institute of Oncology Research (IOR)
in cooperation with the American Association for Cancer Research
American Association
for Cancer Research
FINDING CURES TOGETHER®
15–ICML
Preliminary Program
and Call for Abstracts
JUNE 18–22.2019
PALAZZO DEI CONGRESSI
LUGANO (SWITZERLAND)
Index
2 Contact details
3 Welcome
Organizing Committee and
Advisory Board
4 General Information
7 Hotel Accommodation
9 Travel Arrangements
10 Abstract Submission
14 Registration information
17 Provisional Scientific
Program
19 Program at a Glance
ICML Secretariat:
Foundation for the Institute
of Oncology Research (IOR)
via Vela 6
6500 Bellinzona
Switzerland
VAT number:
CHE-110.407.651 IVA
ICML and ICML
Foundation for the IOR Organizing Committee Cristiana Brentan
President: Chairman: scientific program
and general information
Franco Cavalli Michele Ghielmini cristiana.brentan@lymphcon.ch
Tel: +41 91 811 86 66 Tel: +41 91 811 94 10 Orietta Lugli
franco.cavalli@eoc.ch michele.ghielmini@eoc.ch exhibition, satellite symposia,
ancillary meetings
orietta.lugli@lymphcon.ch
Chiara Saporiti
registrations and accounting
Printed and mailed registration@lymphcon.ch
by courtesy of
Tel. +41 91 922 05 75
15–ICML www.lymphcon.ch
3
Welcome to 15–ICML
The International Conference on Malignant Lymphoma (ICML) has become, since its first edition in 1981, a
must-attend event for the scientific community involved in the study and treatment of lymphoid neoplasms.
Its growing success has required, over the years, quite important logistical changes (e.g. broadcast of
sessions in overflow rooms, parallel sessions in the nearby university and cinema), but has not changed
the main aim of ICML: to permit the presentation of the most recent data - basic, translational and clinical
- about lymphoma and the discussion among haematologists, clinical oncologists, radiation oncologists,
paediatricians, pathologists and leading researchers from all over the world.
Also the Organising Committee’s enthusiasm has not changed and, with the precious help of the many
colleagues and friends of the Advisory Board, we have already defined a very interesting frame of the
15-ICML scientific program.
The long lasting collaboration with the European School of Oncology (ESO) will continue, with the
organisation of the full immersion course on “Leukemia and Lymphoma”, held in Lugano just before our
conference, and with the inclusion of ICML in the Certificate of Competence in Lymphoma.
Also the cooperation with the American Association for Cancer Research (AACR) continues and grows: we
feel honoured to collaborate with AACR friends, who will start a new adventure in holding a meeting on
malignant lymphoma in the USA.
We invite the submission of high-quality abstracts on all aspects of lymphoid neoplasms, including multiple
myeloma and CLL. The very short interval between the deadline of the abstract submission (March 15) and
the conference will allow the inclusion of abstracts reporting the most recent results.
As always, due to time constraints, only a limited number of abstracts can be selected for proffered papers
and, to assure a fair selection, all abstracts will be reviewed by at least 7 international experts.
We look forward to welcoming you to Lugano in June 2019.
Franco Cavalli Michele Ghielmini
ICML President Chairman of ICML Organizing Committee
ORGANIZING COMMITTEE Andreas Engert, Cologne (Germany)
(based in Bellinzona, Switzerland): Jonathan W. Friedberg, Rochester, NY (USA)
Francesco Bertoni Gianluca Gaidano, Novara (Italy)
Franco Cavalli – ICML President Philippe Gaulard, Créteil (France)
Michele Ghielmini – Chairman Mary K. Gospodarowicz, Toronto (Canada)
Alden Moccia Peter W.M. Johnson, Southampton (UK)
Bertrand Nadel, Marseilles (France) – Brad S. Kahl, St. Louis, MO (USA)
Representative of AACR, Ralf Küppers, Essen (Germany)
American Association for Cancer Research John P. Leonard, New York, NY (USA)
Fedro Peccatori, Milan (Italy) – T. Andrew Lister, London (UK)
Representative of ESO, Markus G. Manz, Zurich (Switzerland)
European School of Oncology Ari M. Melnick, New York, NY (USA)
Davide Rossi
Koichi Ohshima, Kurume (Japan)
Anastasios Stathis
Astrid Pavlovsky, Buenos Aires (Argentina)
Georg Stüssi
Emanuele Zucca Leticia Quintanilla-Martinez de Fend, Tübingen
(Germany)
ADVISORY BOARD: S. Vincent Rajkumar, Rochester, MN (USA)
James O. Armitage, Omaha, NE (USA) – Kerry J. Savage, Vancouver BC (Canada)
Chairman John F. Seymour, Melbourne (Australia)
Elias Campo, Barcelona (Spain) Margaret A. Shipp, Boston, MA (USA)
Bruce D. Cheson, Washington, D.C. (USA) Lena Specht, Copenhagen (Denmark)
Nicholas Chiorazzi, Manhasset, NY (USA) Catherine Thieblemont, Paris (France)
Wee Joo Chng, Singapore (Singapore) Umberto Vitolo, Turin (Italy)
Riccardo Dalla-Favera, New York, NY (USA) Anas Younes, New York, NY (USA)
Stephan Dirnhofer, Basel (Switzerland) Wilhelm Wössmann, Hamburg (Germany)
Martin Dreyling, Munich (Germany) Weili Zhao, Shanghai (China)
4
GENERAL INFORMATION
Venue
The 15th International Conference on Malignant Lymphoma will take place in
the Lugano Convention Centre, Palazzo dei Congressi.
Palazzo dei Congressi is in the centre of the city (it’s a 10-minute walk from
the central railway station), but overlooks the beautiful city park (Parco Ciani)
and faces the lake of Lugano. Its rooms will host the scientific general sessions
and the satellite symposia.
Some of “Meet the Professor”, “Focus on…” and other parallel sessions will
be held in additional large conference rooms which are 5-minute walk from the
main convention centre (Cinema Corso and University). The same halls serve
also as overflow rooms for the main sessions, held in Palazzo dei Congressi.
For the first time, it will be possible to submit questions to the speaker even
from the halls where sessions are broadcasted.
Lunches, coffee breaks, poster sessions and the commercial exhibition will
take place in the “Marquee Parco Ciani”, a large gazebo built in Parco Ciani,
overlooking the lakeshore and connected to Palazzo dei Congressi by a covered
walkway.
Participant profile
The 15-ICML will bring more than 3’000 physicians to Lugano from all
over the world: haematologists, clinical oncologists, radiation oncologists,
paediatricians, pathologists and leading researchers involved in the study and
treatment of lymphoid neoplasms.
Demographics from 14-ICML (June 2017):
14 ICML – Participants per country Argentina
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
France
Germany
Greece
Israel
Italy
Japan
Netherlands
Poland
Portugal
Russia
Spain
Sweden
Switzerland
United Kingdom
United States
Other
15–ICML www.lymphcon.ch
5
14 ICML – Participants per continent
Africa
Asia
Europe
North America
Oceania
South America
Continuing Medical Education
Application for European CME accreditation (ECMEC) will be made to the
European Union of Medical Specialties-European Accreditation Council for
Continuing Medical Education (UEMS-EACCME®). European credits are
recognised by the American Medical Association (AMA).
Collaboration with the European School of Oncology (ESO)
The 15-ICML program will be part of the third edition of the Certificate of
Competence in Lymphoma, a 14 months ECTS program developed by the
European School of Oncology (ESO) and academically recognized by the Ulm
University. The aim of the Certificate of Competence is to provide a curriculum
of studies to advance knowledge and science in the management of lymphoma
patients. Further information can be obtained by visiting www.eso.net
Immediately before the 15-ICML, the 2019 Full Immersion Course on
Leukaemia and Lymphoma will take place. This is an intensive and interactive
course organised in co-operation with ESO.
The international faculty will guide participants through the complexity of
biology and important clinical problems in leukaemias and lymphomas, offering
interactive case-presentations, small group seminars, and ample discussion
slots. There will also be opportunities for informal exchange of ideas and views
among the participants and the experts.
Attendance will be limited to 80 participants and registrations will be received
on a first-come/first-served basis.
Date: 15-17 June, 2019
Location: Hotel De la Paix, Lugano
Further information can be obtained from the ESO Bellinzona Office
(dknupfer@eso.net) or by visiting www.eso.net
www.lymphcon.ch 15–ICML
6
Some of 14-ICML Post-ICML events:
23-25 June, 2017
International
Oncology Forum
«White Nights»
Russian Society of
Oncohematologists
St. Petersburg,
Russia
30 June - 02 July, 2017
Best of 14-ICML
Lugano
Mumbai Hematology
Group
Mumbai, India
29 September, 2017
14-ICML Highlights
Saudi Society of
Blood & Marrow
Transplantation
(SS-BMT)
Jeddah, Saudi Arabia
15–ICML www.lymphcon.ch
7
Insurance
The ICML Organizing Committee bears no responsibility for untoward events
in connection with, before, during and after the congress. Participants are
strongly advised to obtain their own personal and travel insurance coverage.
Visa
Citizens of some foreign countries will need a visa to enter Switzerland. An
overview of visa provisions is available visiting www.lymphcon.ch – individual
and group registration information.
Please note that only delegates who successfully complete their registration to
the conference can receive a Letter of Invitation to submit a visa application.
Italian Delegates
Sponsors of Italian delegates who need an AIFA pre-request should address
their requests to:
Barbara Mantegazza
Aria di Viaggi Srl
Congress and Fair Department
Via Matteo Bandello, 1
20123 Milan (Italy)
P.I. 02818040152
IATA 38220346
Tel. +39 02.4818691
Photographs and videos
ICML reserves the right to photograph and videotape the congress and
participants and to use such photographs and videos in any internal and
external communication referring to ICML (website, Preliminary Program and
Call for Abstracts or other publications). By registering, consent to such uses
is assumed.
HOTEL ACCOMMODATION
Booking of hotel accommodation should be made contacting:
Amiconi Consulting SA
Via al Forte 10
CH-6900 Lugano, Switzerland
Tel: +41 (0)91 921 38 12
Fax: +41 (0)91 921 38 13
e-mail: info@amiconiconsulting.ch
www.amiconiconsulting.ch
Due to heavy room demand, early booking is advisable in order to arrange
proper accommodation.
All efforts will be made to assign hotel rooms according to the participants’
choice. However, should this not be possible, alternative category and/or
location will be provided.
www.lymphcon.ch 15–ICML
be global. be one.
oneworld® is proud to be your
official airline alliance.
The oneworld network covers
more than 1,000 destinations in
150 plus countries, so we can get
you anywhere you need to be.
Learn more at oneworld.com
an alliance of the world's leading airlines working as one.
American Airlines British Airways Cathay Pacific Finnair Iberia Japan Airlines LATAM
Malaysia Airlines Qantas Qatar Airways Royal Jordanian S7 Airlines SriLankan Airlines
oneworld benefits are available only to passengers on scheduled flights that are both marketed and operated by a oneworld member airline
(marketed means that there must be a oneworld member airline’s flight number on your ticket). For information on oneworld, visit www.oneworld.com.
American Airlines, British Airways, Cathay Pacific, Finnair, Iberia, Japan Airlines, LATAM Airlines, Malaysia Airlines, Qantas, Qatar Airways, Royal Jordanian,
S7 Airlines, SriLankan Airlines and oneworld are trademarks of their respective companies. LATAM Airlines (Paraguay) is currently not a part of oneworld.
9
TRAVEL ARRANGEMENTS
Lugano is situated in Ticino, the italian-speaking part of Switzerland, close to
the Italian border.
The city is well connected, both with regards to motorway as well as railway
networks, and it has several airports in the surroundings.
Lugano-Agno (LUG) airport is served by domestic flights departing from Geneva
(GVA) and Zurich (ZRH), the major Swiss international airport.
The train connection from Zurich airport (about 220 km from Lugano) is an
efficient and pleasant option: with the New Rail Link through the Alps, opened
in December 2016, the journey - through some of Switzerland’s most beautiful
landscapes and views – takes about 2 hours.
Please visit http://www.sbb.ch for prices, timetables and online bookings.
From June 2018 Lugano is also connected by train to Milan-Malpensa (MXP),
the closest international airport (about 60 km from Lugano, in Italy). The train
trip takes 1 hour and 45 minutes.
Please visit http://www.tilo.ch for prices and timetables.
Different bus connections (Giosy Tours-Malpensa Express CH, Lugano Services,
Jetbus) are also available and the shuttle trip takes about 1 hour.
Other options are Milan-Linate (LIN) and Bergamo-Orio al Serio (BGY) airports,
both in Italy, connected to Milan by bus and then to Lugano by train.
Private transfer services
Amiconi Consulting SA can be contacted to arrange private transfer services
from and to the airports (Milan-Linate, Milan-Malpensa, Bergamo-Orio al Serio
and Lugano-Agno) and in the city of Lugano and its surroundings, for both
individuals and groups.
Official Carrier
For the first time, 15-ICML will partner with the oneworld airline alliance to
offer to participants discounts on flights and many other benefits for their air
travel to the conference, as follows:
• Travel up to seven days before and seven days after the event.
• Flights available from all oneworld member airlines and affiliates.
• A user-friendly booking tool showing the most convenient flight options.
• 24-hour support via email or phone.
• Rewards and tier status points on eligible oneworld flights.
• Frequent flyer privileges including access to some 650 premium airport
lounges worldwide, fast track at security lanes in selected airports and extra
baggage allowance.
• Seamless connections and quality service on oneworld member airlines.
The online booking tool is available at www.oneworld.com/events as
of September 2018.
To access the online booking tool and take advantage of the offer, enter event
code OW44B17.
www.lymphcon.ch 15–ICML10
ABSTRACT SUBMISSION
(deadline: Friday, March 15, 2019, 17:59 CET)
Abstracts for oral presentations (general sessions and “Focus on…” sessions)
and poster presentation must be submitted online from Saturday, December 1,
2018 until Friday, March 15, 2019, 17:59 CET via www.lymphcon.ch.
Abstracts can be related to all aspects of biology and treatment of lymphoid
neoplasms.
The submission of an abstract does not constitute registration for ICML.
Abstract presenters must register to attend the meeting. Simultaneous abstract
submission and registration for the congress are highly recommended.
Notification regarding abstract evaluation results (acceptance for oral or poster
presentation, inclusion in the Abstract Book or rejection) will be sent to the
first author/presenter by Friday, May 3, 2019.
Early registration fee applies for presenters of abstracts selected for oral
presentation.
Encore abstracts
Submission of original scientific material unpublished at the time of the
abstract submission deadline is encouraged.
Encore abstracts are accepted only if already submitted to and/or presented at:
– regional or national meetings
– ASCO 2019 and EHA 2019, the large international meetings which are or-
ganized in the same period as ICML (May – July) by the American Society
of Clinical Oncology (ASCO) and the European Hematology Association
(EHA).
Except for the above mentioned situations, during submission, first authors
are asked to certify that the submitted abstract has neither been nor will be
previously published before release of 15-ICML Abstract Book (Wednesday,
June 12, 2019).
Updated analyses must substantially differ from previously published
manuscripts.
Ongoing trials abstracts
Abstracts describing trials in progress can be submitted, provided that:
– patient enrolment has already started
– new patient accrual is still possible
Text of ongoing trials abstracts is expected to include only the 2 following
sections: Introduction and Methods.
These abstracts will be evaluated for oral presentation (in a general session
or a “Focus on Ongoing trials” session), poster presentation or inclusion in
the Abstract Book. The presentation format will be decided by the Organizing
Committee on the basis of the evaluation results and the scientific program
structure.
15–ICML www.lymphcon.ch11
Late-Breaking Abstracts
(deadline: Wednesday, April 24, 2019, 17:59 CEST)
Late-Breaking Abstracts may be submitted for studies that will have conclusive
data available after the regular abstract submission deadline.
A preliminary abstract (placeholder abstract) must be submitted online by the
regular abstract deadline (March 15, 2019, 17:59 CET).
A covering letter must be sent to ICML Secretariat (cristiana.brentan@
lymphcon.ch), indicating the data expected to be available by the late-breaking
abstract deadline.
Only abstracts anticipating very high quality research findings will be accepted.
A member of ICML Organizing Committee will contact the first author in order
to discuss the study in detail.
No Late-Breaking Abstract will be considered without the submission of the
placeholder abstract and the covering letter.
First author responsabilities
The submission of an abstract constitutes a formal commitment by the first
author to present the abstract (if accepted) orally or as a poster.
The first author serves as presenter and primary contact for all correspondence
regarding the abstract.
Upon submission of an abstract, the first author/presenter is responsible for
the following:
• ensuring that all authors have read the abstract and agreed to be co-authors;
• forwarding all correspondence regarding the abstract to all co-authors;
• releasing abstract copyright to John Wiley and Sons, Inc. (publisher of
15-ICML Abstract Book as supplement to “Hematological Oncology”), for
inclusion in ICML abstract book and its licensee publications with educational
purposes;
• giving permission to record his/her presentation during 15-ICML for multimedia
coverage, release to attendees and licensees for educational purposes;
• disclosing any conflict of interest, declaring the name of the company (s)he
maintains a “relevant financial relationship”* with. Unless otherwise indicated,
it is implied that there are no conflicts of interests pertinent to the abstract;
*“Relevant financial relationships” are intended those from which the author or any individual with
whom he/she directly shares income has received or may receive financial benefit within the past
24 months. The relationships to declare are: employment or leadership position in a company –
consultant or advisory role - stock ownership – honoraria – research funding – other remuneration.
• releasing copyright and providing conflict-of-interest disclosure on behalf
of co-authors;
• certifying that the same abstract has neither been nor will be previously
published before 15-ICML, except for regional or national meetings, ASCO
2019 and EHA 2019.
Furthermore, the first author/presenter certifies that the abstract will not
be included as such in the scientific material produced in connection with
any satellite symposium held during 15-ICML.
www.lymphcon.ch 15–ICML12
Abstract submission information
During the online abstract submission, the following information will be
required:
First author/presenter complete contact details (first and middle name,
–
surname, department, affiliation, mailing address, city and country,
telephone number, e-mail address), for future correspondence and
notification on the abstract evaluation outcome;
Co-authors’ first and middle name initials, surname, department, affiliation,
–
city and country.
Preference of presentation: Oral presentation (including “Focus on...”
–
sessions) or Poster presentation. The Organizing Committee reserves the
right to conclusively decide the presentation format, on the basis of the
evaluation results and the scientific program structure.
– Ongoing trials abstract eligibility (please check the pertinent paragraph for
conditions).
– Option of withdrawal of the abstract in case of selection for publication only
in the Abstract Book (i.e.: if the abstract is not selected for oral or poster
presentation).
NB: C
hanges of the option of withdrawal are not possible after the submission
deadline.
– Application for a travel award, in case the abstract is selected for oral or
poster presentation. The applicant must be first author/presenter of the
abstract and aged 35 years or younger.
Keywords (minimum 1 – maximum 3), to be selected from the list available
–
online.
Acceptance of abstract submission policy and regulations including first
–
author/presenter responsibilities and in particular:
1.
release of copyright and permission to multimedia recording of
presentation for educational purposes, also on behalf of the co-authors;
2. disclosure of conflict of interest, also on behalf of the co-authors;
3. no prior publication of the same abstract, except for regional and
national meetings, ASCO 2019 and EHA 2019;
4. no inclusion of the same abstract in the scientific material produced in
connection with any satellite symposium.
5. withdrawal policy: abstracts selected for oral or poster presentation
must be presented, unless indicated during the submission. Abstract
withdrawal requests received after the deadline can not be accepted. If
the presenting author can not present the abstract, (s)he should
nominate a co-author and inform ICML Secretariat (cristiana.brentan@
lymphcon.ch) of the replacement as soon as possible.
Guidelines for abstract preparation
• Abstracts must not be longer than 2’500 characters (text and table included;
title, authors’ list and spaces not included).
15–ICML www.lymphcon.ch13
The title must not exceed 150 characters (spaces not included).
•
Names of cooperative study groups should appear in the title, as they can
not be included in the authors’ list.
• The number of listed co-authors must be limited to thirty-five (35).
First author/presenter name will be underlined. All authors will be listed
with first and middle name initials, surname, department, affiliation, city
and country.
Please note that, in order for affiliations to be grouped properly, the exact
same information for affiliation, department, city, and country fields must
be entered.
• All abstracts (except for ongoing trials) should include the following
4 sections: Introduction, Methods, Results, Conclusions.
• Only one brief and simple data table is permitted in the text of the abstracts.
The table counts for 350 characters.
One image can be submitted and it’s not included in the character count.
•
Only JPG, GIF or PNG file can be uploaded.
The image options must be: Width and Height (in px): 500; Size (in KB):
1000; DPI: 300.
Images not adhering to these options and images with no readable texts
will be removed from the abstract book without further recourse to the first
author.
• Compounds should be mentioned with the generic name in lower case.
Commercial names may not be used in the title of the abstract. Commercial
names are admitted in the text, in brackets and with the ® symbol, following
the generic name, i.e. ‘generic (Commercial®)’.
Educational Book and Abstract Book
All selected abstracts will be included in the Abstract Book, supplement to
“Hematological Oncology” (John Wiley and Sons, Inc.), published online on
the pertinent Wiley Online Library website as of Wednesday, June 12, 2019.
Prior to this date, submitted abstracts are treated as confidential by ICML
(Organizing Committee, Advisory Board, 15-ICML reviewers), first author,
co-authors, research sponsors.
Summaries of the Educational sessions will be included in the Educational
Book distributed to attendees on site and also available online.
Travel Grants and Merit Award
Based on funding availability, a limited number
of travel grants, sponsored by the Swiss Cancer
League and possibly by other contributors, will
be provided to young investigators (less than
35 years), whose abstract has been accepted for oral or poster presentation.
The selection will be made on the basis of the abstract evaluation results. The
travel grant, meant to defray travel expenses for attending ICML, can be applied
for by eligible first authors during the abstract submission.
Based on funding availability, a “merit award” will be given to the young
investigator author of the highest-scoring abstract and selected for a travel
grant. The recipient will receive complimentary registration, a monetary
support to attend 15-ICML and will be recognized for his/her scientific merit
during the conference.
www.lymphcon.ch 15–ICML14
REGISTRATION INFORMATION
Due to space restrictions, attendance is limited and registration is available on
a first-come, first-served basis.
Well in advance registration is encouraged.
Registrations will be closed upon reaching the maximum allowed number of
paid registrations.
In this case a waiting list will be opened and further registrations from the list
will be confirmed in case of cancellations.
What the full registration does include
The full registration fee covers access to the scientific sessions, poster session
and Exhibition area, participation in the Satellite Symposia (unless otherwise
indicated by the Symposia’s organizers), a copy of the 15-ICML Educational
Book, three lunches, refreshment breaks and the Farewell Aperitif on Friday,
June 21, 2019.
15-ICML Abstract Book, supplement to «Hematological Oncology» (John WIley
and Sons, Inc.) will be available online on the Wiley Online Library website as
of Wednesday, June 12, 2019.
All delegates staying in a hotel, hostel or camping in the Ticino Region and
subject to the full tourist tax are entitled to the Ticino Ticket, a pass valid for
the duration of their stay.
Ticino Ticket holders can use free of charge the regular public transportation
system (which includes trains, buses and postal buses of the “Arcobaleno
Community”) and receive a discount to cable car and funicular companies
and other tourist attractions.
Details are available at: https://www.ticino.ch/en/ticket.html
Furthermore, a private bus service, running at scheduled times from and to
hotels, is granted to delegates staying in Italy or in hotels not reached by
public transportation and having booked through 15-ICML appointed agency,
Amiconi Consulting SA.
Detailed timetable will be available at www.lymphcon.ch in the spring 2019.
Registration fee
The registration fees are based on the following deadline schedule:
Early Registration CHF 1’000.– until February 28, 2019
if places are still available
Late Registration CHF 1’400.– from March 1, until June 11, 2019
if places are still available
Payment information
Payment can be processed by credit card (Visa, Mastercard and American
Express), through ICML online payment system, or by bank transfer.
The wire transfer, with no costs to the beneficiary, should be made to:
Account holder: Fondazione per l’Istituto Oncologico di Ricerca (IOR)
Account name: ICML
Account number: 336 9742 C001C
Bank name: Banca dello Stato del Canton Ticino
15–ICML www.lymphcon.ch15
Bank address: via Pioda 7, 6900 Lugano, Switzerland
IBAN code: CH47 0076 4336 9742 C001 C
SWIFT code: BSCTCH22LUG
Clearing number: 00764
The name of the participant or the group registration should be clearly stated
on the bank transfer.
INDIVIDUAL REGISTRATION
Application to participate in the 15-ICML can be made online at
www.lymphcon.ch and registration is confirmed when full payment is settled,
by credit card or by bank transfer.
Confirmation of registration and invoice (if pertinent fields are filled in) will be
sent within 5 working days after the payment is processed.
ICML Secretariat may revoke tentative registrations if payment is not settled
within 10 days after submission of online registration.
The registration form can be obtained at www.lymphcon or contacting the
ICML Secretariat.
Cancellation of individual
+41 91 850 10 61
phone: +41 91 863 20 93
Via S. Gottardo 18D
CH - 6532 Castione
EVENTMORE SA
registration
fax:
Event Coordinator - Structural consultant
Mark.Saggia@eventmore.ch
Individual registration fee is refundable
www.eventmore.ch
+41 78 706 30 12
Mark Saggia
(minus 20% administration charges) if
©
email notification is received by ICML
Secretariat by Thursday, May 24, 2019.
Reimbursements will be processed after
the congress.
Individual registration
name change
Name changes, with no extra fees, will
be accepted by email notification by
Thursday, May 24, 2019.
After this deadline, a penalty fee of
CHF 200.– will be charged for each name
change.
Invitation Letter
Delegates who successfully complete
their registration for the conference can
receive an Invitation Letter to submit a
visa application. An Invitation Letter can
be requested by providing needed data in
the online registration form.
The invitation letter does not commit ICML
to any financial obligations whatsoever.
www.lymphcon.ch 15–ICML16
GROUP REGISTRATION (minimum: 10 participants)
Summary of the deadlines for Group Registration
Payment of early fees CHF 1’000.– until February 28, 2019
(no-name registrations) if places are still available
Payment of late fees CHF 1’400.– from March 1 until June 11, 2019
if places are still available
Participants list by May 24, 2019
(names and addresses)
Collection of the material from June 17, 2019
Group administrators should complete the group registration form available
online at www.lymphcon.ch/Registrations/GroupRegistration, specifying the
number of no-name registrations, group name, preferred method of payment
(credit card or bank transfer) and housing information (booking source, booked
rooms number and hotel name should be provided).
Once the payment is settled, the group administrator will be able to include the
required personal data of each participant in the conference database, using
the group registration username and password.
Group administrators must provide complete information on each participant
(including the full address of the institute and the personal e-mail address) by
Thursday, May 24, 2019.
Group registration name changes
Name changes, at no extra fee, are allowed up until Thursday, May 24, 2019.
Name changes must be processed online accessing to the group record through
the log in credentials.
After this deadline, a penalty fee of CHF 200.– will be charged for each name
change and for each name not yet provided.
Cancellation of group registration
Group registration fees are refundable (minus 20% administration charges) if
email notification is received by ICML Secretariat by Monday, February 11, 2019.
After this deadline, group registration fees will be not refundable.
Reimbursements will be processed after the congress.
Invitation letter
Group administrators can ask for delegates’ invitation letters sending an email
to registration@lymphcon.ch and providing delegates’ passport details.
Invitation letters can be issued only for delegates who successfully complete
their registration for the conference.
The invitation letter does not commit ICML to any financial obligations whatsoever.
Congress materials for groups will be available for pick up at preassigned times
on Monday, June 17, 2019, at the Registration Desk in Palazzo dei Congressi
main hall.
Please ask for an appointment sending an e-mail to registration@lymphcon.ch.
15–ICML www.lymphcon.ch17
PROVISIONAL SCIENTIFIC PROGRAM
Based on the abstracts received and accepted for oral presentation, general
sessions will be devoted to either specific subtypes of lymphoid neoplasia (e.g.
mantle cell lymphomas, follicular lymphomas, T-cell lymphomas, etc), or to the
presentation of laboratory and clinical research data grouped around a biologic
topic (for example, microenvironment, signalling pathway, surface antigens).
“Focus on...” are parallel oral sessions highlighting abstracts of scientific
value but not selected for oral presentation during the general sessions. These
sessions will be run in parallel and each will be focused on a particular topic.
The one-hour sessions will consist of six presentations of 10 minutes each,
including discussion.
Key Note Lectures:
Henry Kaplan Memorial Lecture and San Salvatore Foundation Award
–
Title to be announced
Carl H. June, Philadelphia, PA (USA)
– G
ianni Bonadonna Memorial Lecture (supported by American Association
for Cancer Research)
“Precision Epigenetic Therapy for B-cell lymphomas”
Ari M. Melnick, New York, NY (USA)
– J ohn Ultmann Memorial Lecture (supported by European School of Oncology)
“Thirty years of T-cell lymphomas”
Philippe Gaulard, Créteil (France)
Educational symposia (parallel sessions):
a. “Treating Hodgkin Lymphoma in the new millennium”
New first lines: Peter W.M. Johnson, Southampton (UK)
R/R: Ann S. LaCasce, Boston, MA (USA)
Elderly patients: Andreas Engert, Cologne (Germany) - Chairman
b. “New drugs for NHL: beyond chemotherapy”
Immunotherapies: Renier J. Brentjens, New York, NY (USA)
New drugs for old targets: Gilles A. Salles, Lyon (France) - Chairman
New drugs for new targets: Anas Younes, New York, NY (USA)
Meet the Professor sessions:
1. Multiple myeloma: every year a new standard? – S. Vincent Rajkumar,
Rochester, MN (USA)
2. How to approach CLL in clinical practice – Michael Hallek, Cologne
(Germany)
3. Managing the toxicities of CAR T-cell therapy – Sattva S. Neelapu,
Houston, TX (USA)
4. What we should know about NK/T-cell lymphomas – Weili Zhao, Shanghai
(China)
5. Cutaneous lymphomas – Werner Kempf, Zurich (Switzerland)
6. PCNSL, a curable disease – Tracy T. Batchelor, Boston, MA (USA)
7. Breast implant associated ALCL and other rare T-cell lymphomas –
Laurence de Leval, Lausanne (CH)
8. Liquid biopsy: a clinical tool, already? – Ash A. Alizadeh, Stanford, CA (USA)
9. Double Hit lymphoma, so what? – Andrew Davies, Southampton (UK)
10. The modern approach to mantle cell lymphoma – Simon Rule, Plymouth
(UK)
11. Hairy Cell leukemia, new treatment options – Brunangelo Falini, Perugia
(Italy)
www.lymphcon.ch 15–ICML18
12. Rare B cell lymphomas in children and adolescents – Wilhelm Wössmann,
Hamburg (Germany) and Leticia Quintanilla-Martinez de Fend, Tübingen
(Germany)
Clinical case discussion sessions have presenters of outstanding centers
addressing cases which are not trivial nor very rare, but rather situations
commonly encountered where the solution remains controversial. The format is
a sort of Europe vs. USA debate: we had Lysa (France) vs Mayo Clinic in 2013, FIL
(Italy) vs New York centers in 2015 and German vs Californian institutes in 2017.
In 2019 we will have the following Spanish vs Texan experts presenting cases
and discussing the treatment options:
1. HL: Ana Maria Sureda Balari vs Hun Ju Lee
2. FL/Indolent Lymphoma: Mariano Provencio Pulla vs Loretta J. Nastoupil
3. PTCL: Alejandro Martín vs Nathan H. Fowler
4. DLBCL: Eva Giné Soca vs Jason R. Westin
5. CLL: Julio Delgado vs Philip A. Thompson
6. Clinico-pathological difficult cases: Armando Lopez-Guillermo vs Fredrick
B. Hagemeister
7. Radiotherapy in lymphoma: TBD vs Bouthaina S. Dabaja
Ongoing trials presentation: this session will comprise abstracts describing trials
in progress. Conditions for being selected for presentation at this session are:
– already started enrolment,
– still possible accrual of new patients.
The session should not be regarded as an advertisement for new drugs. Trials
which are close to completion (i.e. not available for other possible participants)
and closed trials will not be considered for presentation.
15-ICML Highlights
“Take home messages”
Speaker to be announced
Special AACR-ICML session
After the 2015 and 2017 positive and fruitful experiences, AACR and ICML
will organize once again in 2019 a special joint session. The session will be
devoted to the role of pre-clinical models as bridges to early clinical phases.
Special sessions devoted to radiotherapy, organized in collaboration with ILROG
(International Lymphoma Radiation Oncology Group): two satellite workshops
open to all 15-ICML attendees will take place.
Details will be available closer to the event at www.lymphcon.ch.
IBSA Foundation for Scientific Research - Special Forum
As in 2017, when the event “Basic mechanisms of cancer immunotherapy”
took place, ICML participants will again have the possibility to join the IBSA
Foundation Special Forum. The forum will be organised in the University
Auditorium and the program will be defined in collaboration with the Foundation
for the Institute of Oncology Research (IOR).
IV International Workshop on Canine Lymphoma
This well-attended meeting fosters interdisciplinary contacts between
researchers studying lymphoma in canine and other species. The 2019 edition
will comprise an invited plenary lecture on a cutting-edge topic, an update on
the activities of the European Canine Lymphoma Network, a round table on
state-of-the-art on canine multicentric lymphoma staging, and, for the first
time, a session with free oral research presentations.
15–ICML www.lymphcon.chTUESDAY, JUNE 18
Room A Room B I Room B II Cinema Auditorium Aula Magna
Palazzo dei Congressi Palazzo dei Congressi Palazzo dei Congressi Corso University University
7:15
7:30
7:45
8:00
www.lymphcon.ch
8:15
8:30
8:45
9:00
9:15
9:30
9:45
10:00
10:15
10:30
10:45
11:00
11:15
11:30
11:45
12:00
12:15
12:30
12:45
CLOSED WORKSHOP
13:00
by invitation only
13:15
(08:30-17:30)
13:30
13:45
14:00
available GILEAD SCIENCES Ltd. INCYTE CORPORATION
14:15
satellite symposium satellite symposium satellite symposium
14:30
(13:30-15:00) (13:30-15:00) (13:30-15:00)
14:45
15:00
15:15 WORKSHOP
15:30 open to all 15-ICML participants
15:45 LYMPHOMA
16:00 RADIOTHERAPY
16:15 BRISTOL-MYERS time TBD
16:30
NOVARTIS GILEAD SCIENCES Ltd. organized by International
SQUIBB
16:45
satellite symposium satellite symposium Lymphoma Radiation
satellite symposium
17:00
(16:00-17:30) (16:00-17:30) Oncology Group - ILROG
(16:00-17:30)
17:15
17:30
17:45
18:00
18:15
18:30
18:45
19:00
ROCHE BAYER TAKEDA ONCOLOGY AVAILABLE AVAILABLE
19:15
satellite symposium satellite symposium satellite symposium satellite symposium satellite symposium
19:30
(18:30-20:00) (18:30-20:00) (18:30-20:00) (18:30-20:00) (18:30-20:00)
19:45
20:00
15–ICML
Please note that this draft program was printed and circulated in May 2018. Final program will differ in some details. In particular, the content of the general sessions and “Focus on…” sessions will be defined on the basis of the abstract evaluation.
1920
WEDNESDAY, JUNE 19
Room A Room B Marquee Cinema Auditorium Aula Magna
Palazzo dei Congressi Palazzo dei Congressi Parco Ciani Corso University University
7:15
7:30
7:45
EXHIBITION AREA and
8:00
POSTER SESSION
15–ICML
8:15
(09:00-17:00)
8:30
8:45 Meet the Professor (8:30-9:15) Meet the Professor (8:30-9:15) Meet the Professor (8:30-9:15) Meet the Professor (8:30-9:15) Meet the Professor (8:30-9:15)
9:00 POSTER SESSION
9:15 SET UP
9:30 (09:00-12:00)
9:45 Meet the Professor (9:30-10:15) Meet the Professor (9:30-10:15) Meet the Professor (9:30-10:15) Meet the Professor (9:30- 10:15) Meet the Professor (9:30-10:15)
10:00
10:15
10:30
COFFEE (10:15-10:45)
10:45
11:00
Educational Symposium A
Educational Symposium B broadcasting of broadcasting of broadcasting of
11:15
(10:45-12:00)
(10:45-12:00) Educational Symposium B Educational Symposium A Educational Symposium A
11:30
Room A - Cinema Corso
Room B - Marquee (10:45-12:00) (10:45-12:00) (10:45-12:00)
11:45
Aula Magna
12:00
12:15
LUNCH TIME and
12:30
POSTER VIEWING
12:45
(12:00-13:00)
13:00
13:15
Opening of the Conference broadcasting of broadcasting of broadcasting of
13:30
HENRY KAPLAN MEMORIAL LECTURE (13:00-14:00) Opening of the Conference Opening of the Conference Opening of the Conference
13:45
Room A - B - Marquee - Cinema Corso - Aula Magna Henry Kaplan Lecture Henry Kaplan Lecture Henry Kaplan Lecture
14:00
14:15
PLENARY SESSION
broadcasting of broadcasting of broadcasting of
14:30
(14:05-15:05)
PLENARY SESSION PLENARY SESSION PLENARY SESSION
14:45
Room A - B - Marquee - Cinema Corso - Aula Magna
15:00
15:15
COFFEE (15:05-15:35) COFFEE (15:05-15:35)
15:30
15:45
AACR-ICML JOINT SESSION
broadcasting of broadcasting of broadcasting of
16:00
(15:35-16:35)
AACR-ICML Joint Session AACR-ICML Joint Session AACR-ICML Joint Session
16:15
Room A - B - Marquee - Cinema Corso - Aula Magna
16:30
16:45
17:00 “Focus on…” session “Focus on…” session “Focus on…” session “Focus on…” session “Focus on…” session
17:15 (16:45-17:45) (16:45-17:45) (16:45-17:45) (16:45-17:45) (16:45-17:45)
17:30
17:45
18:00
18:15
18:30
18:45
19:00
JANSSEN ONCOLOGY ABBVIE, INC. MORPHOSYS AG AVAILABLE
19:15
satellite symposium satellite symposium satellite symposium satellite symposium
19:30
(18:30-20:00) (18:30-20:00) (18:30-20:00) (18:30-20:00)
19:45
20:00
www.lymphcon.ch
Please note that this draft program was printed and circulated in May 2018. Final program will differ in some details. In particular, the content of the general sessions and “Focus on…” sessions will be defined on the basis of the abstract evaluation.THURSDAY, JUNE 20
Room A Room B Marquee Cinema Auditorium Aula Magna
Palazzo dei Congressi Palazzo dei Congressi Parco Ciani Corso University University
7:15
7:30
7:45
8:00 EXHIBITION AREA and
www.lymphcon.ch
8:15
POSTER SESSION
Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45) 9:00-17:00 Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45)
8:30
8:45
9:00
9:15 SESSION 1:
9:30 broadcasting of
Clinical case discussion Lymphoma Biology Clinical case discussion Clinical case discussion Clinical case discussion
9:45
SESSION 1
(09:00-10:30) (9:00-10:30) (09:00-10:30) (09:00-10:30) (09:00-10:30)
(9:00-10:30)
10:00 Room B - Marquee
10:15
10:30
10:45
COFFEE (10:30-11:00)
11:00
11:15 SESSION 2: broadcasting of broadcasting of broadcasting of
11:30
Primary Mediastinal B-Cell Lymphoma (11:00-12:00) SESSION 2 SESSION 2 SESSION 2
Room A - B - Marquee - Cinema Corso - Aula Magna
11:45
12:00
12:15 LUNCH TIME and
12:30
POSTER VIEWING
(12:00-13:00)
12:45
13:00 GIANNI BONADONNA MEMORIAL LECTURE
13:15
broadcasting of broadcasting of broadcasting of
(13:00-13:45) Gianni Bonadonna Lecture Gianni Bonadonna Lecture Gianni Bonadonna Lecture
13:30 Room A - B - Marquee - Cinema Corso - Aula Magna
13:45
14:00 SESSION 3: WORKSHOP
14:15
Hodgkin Lymphoma broadcasting of broadcasting of open to all 15-ICML broadcasting of
14:30
(13:50-15:05) SESSION 3 SESSION 3 participants SESSION 3
Room A - B - Marquee - Cinema Corso - Aula Magna LYMPHOMA
14:45
15:00
RADIOTHERAPY
COFFEE (15:05-15:35) COFFEE (15:05-15:35) time TBD
15:15
organized by International
15:30 SESSION 4: SESSION 5: Lymphoma Radiation
15:45 Targeting the BCR Pathways T-Cell Lymphoma broadcasting of broadcasting of Oncology Group - ILROG broadcasting of
16:00 (15:35-16:35) (15:35-16:35) SESSION 5 SESSION 4 SESSION 4
16:15 Room A - Cinema Corso - Aula Magna Room B - Marquee
16:30
16:45
17:00 “Focus on…” session “Focus on…” session “Focus on…” session “Focus on…” session “Focus on…” session
17:15 (16:45-17:45) (16:45-17:45) (16:45-17:45) (16:45-17:45) (16:45-17:45)
17:30
17:45
18:00
18:15
18:30
18:45
19:00 CELGENE CORPORATION SERVIER CELLTRION Healthcare AVAILABLE
19:15
satellite symposium satellite symposium satellite symposium satellite symposium
(18:30-20:00) (18:30-20:00) (18:30-20:00) (18:30-20:00)
19:30
19:45
20:00
15–ICML
Please note that this draft program was printed and circulated in May 2018. Final program will differ in some details. In particular, the content of the general sessions and “Focus on…” sessions will be defined on the basis of the abstract evaluation.
2122
FRIDAY, JUNE 21
Room A Room B Marquee Cinema Auditorium Aula Magna
Palazzo dei Congressi Palazzo dei Congressi Parco Ciani Corso University University
7:15
7:30
7:45
8:00
EXHIBITION AREA and
15–ICML
8:15
POSTER SESSION
Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45) Meet the Professor (8:00-8:45)
8:30
(9:00-18:30)
8:45
9:00
9:15 SESSION 6:
9:30
broadcasting of
Clinical case discussion Lymphoma Genomics Clinical case discussion Clinical case discussion
9:45
SESSION 6
(09:00-10:30) (9:00-10:30) (09:00-10:30) (09:00-10:30)
10:00
(9:00-10:30)
Room B - Marquee
10:15
10:30
10:45
COFFEE (10:30-11:00)
11:00
11:15
SESSION 7:
broadcasting of broadcasting of broadcasting of
11:30
Advances in CLL (11:00-12:00)
SESSION 7 SESSION 7 SESSION 7
11:45
Room A - B - Marquee - Cinema Corso - Aula Magna
12:00
12:15
LUNCH TIME and
12:30
POSTER VIEWING
12:45
(12:00-13:00)
13:00
13:15
JOHN ULTMANN MEMORIAL LECTURE (13:00-13:45) broadcasting of broadcasting of broadcasting of
13:30
Room A - B - Marquee - Cinema Corso - Aula Magna John Ultmann Lecture John Ultmann Lecture John Ultmann Lecture
13:45
14:00
14:15
SESSION 8:
14:30
Follicular Lymphoma broadcasting of broadcasting of broadcasting of
14:45
(13:50-15:35) SESSION 8 SESSION 8 SESSION 8
15:00
Room A - B - Marquee - Cinema Corso - Aula Magna
IBSA FOUNDATION
15:15 SPECIAL FORUM
15:30 open to all 15-ICML
15:45
COFFEE (15:35-16:05) COFFEE (15:35-16:05)
participants
16:00 time TBD
16:15 SESSION 9:
16:30 Aggressive Lymphoma broadcasting of broadcasting of broadcasting of
16:45 (16:05-17:35) SESSION 9 SESSION 9 SESSION 9
17:00 Room A - B - Marquee - Cinema Corso - Aula Magna
17:15
17:30
17:45
18:00
Farewell Aperitif
18:15
(17:35-18:30)
18:30
18:45
IOSI - THE BIG DEBATE
19:00
(18:30-19:30) AVAILABLE
19:15
supported by GILEAD SCIENCES Ltd. satellite symposium
19:30
(18:30-20:00)
19:45
20:00
www.lymphcon.ch
Please note that this draft program was printed and circulated in May 2018. Final program will differ in some details. In particular, the content of the general sessions and “Focus on…” sessions will be defined on the basis of the abstract evaluation.SATURDAY, JUNE 22
Room A Room B Auditorium
Palazzo dei Congressi Palazzo dei Congressi University
7:15
7:30
7:45
8:00
www.lymphcon.ch
8:15
8:30
8:45 ESO
9:00
SESSION 10: SESSION 11: (European School of Oncology)
9:15
Immunotherapies Mantle Cell Lymphoma ESMIT
9:30
(08:30-10:00) (08:30-10:00) (European School of Multimodality
9:45 Imaging & Therapy)
10:00 “PET IN LYMPHOMA”
10:15
(8:30-10:30)
10:30 SESSION 12: Marginal Zone Lymphoma
10:45
Room A - B
(10:15-11:15)
11:00
11:15 15-ICML HIGHLIGHTS
11:30 “Take Home Messages”
11:45 (11:20-11:45)
12:00 CLOSURE AND FAREWELL (11:50-12:00)
12:15
12:30
12:45
13:00
13:15
13:30
13:45
14:00
14:15
14:30
14:45
15:00
15:15 IV INTERNATIONAL
15:30 WORKSHOP ON CANINE
15:45
LYMPHOMA
open to all 15-ICML
16:00
attendees
16:15 (13:30-18:15)
16:30
16:45
17:00
17:15
17:30
©
17:45
Mark Saggia
18:00
+41 78 706 30 12
www.eventmore.ch
Mark.Saggia@eventmore.ch
18:15
Event Coordinator - Structural consultant
fax:
Please note that this draft program was printed and circulated in May 2018. Final program will differ in some details.
EVENTMORE SA
CH - 6532 Castione
Via S. Gottardo 18D
phone: +41 91 863 20 93
15–ICML
+41 91 850 10 61
In particular, the content of the general sessions and “Focus on…” sessions will be defined on the basis of the abstract evaluation.
23You can also read
